InsiderClue
← All stocks

Vanda Pharmaceuticals Inc.

VNDA Net selling
CIK 0001347178 #3500 in the set updated 19 Sep 2026
Bought (120 mo)
$513.64K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$51.31M
$0.00 on a plan · $16.46M straight out of an exercise
Sold at will
$34.84M
118 of 151 sales
Net
−$50.79M
−$34.33M against sales at will

By person

22 insiders · 169 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Polymeropoulos Mihael Hristos
President and CEO
$504.86K (14)
$21.77M (34) scheduled
−$21.26M
2,704,496
4.47%
$22.36M
+212.6%
Flynn James E
10% owner
—
$19.27M (9)
−$19.27M
4,328,344
7.16%
$35.78M
−21.2%
Birznieks Gunther
SVP, Business Development
—
$2.02M (19)
−$2.02M
494,197
0.8174%
$4.08M
+289.3%
Williams Timothy
SVP & General Counsel
—
$1.55M (19)
−$1.55M
377,450
0.6243%
$3.12M
—
Jones Aranthan II
Chief Corp. Affairs Officer
—
$1.43M (7) scheduled
−$1.43M
81,980
0.1356%
$677.64K
+36.6%
Kelly James Patrick
EVP & Chief Financial Officer
—
$1.16M (11)
−$1.16M
186,869
0.3091%
$1.54M
+131.4%
Moran Kevin Patrick
SVP, CFO & Treasurer
$8.78K (1)
$1.06M (16)
−$1.05M
412,015
0.6814%
$3.41M
+571.2%
Wijkstrom Joakim
SVP, Chief Marketing Officer
—
$706.47K (11)
−$706.47K
333,469
0.5515%
$2.76M
—
Mitchell Stephen Ray
Director
—
$540.03K (6) scheduled
−$540.03K
112,846
0.1866%
$932.77K
+56,323%
DUGAN RICHARD W
Director
—
$505.27K (4) scheduled
−$505.27K
219,054
0.3623%
$1.81M
+3,696%
Gulino Richard L.
SVP, General Counsel & Sec.
—
$395.13K (3) scheduled
−$395.13K
115,073
0.1903%
$951.18K
+187.7%
Watkins Thomas
Director
—
$282.92K (3) scheduled
−$282.92K
63,064
0.1043%
$521.28K
—
Baroldi Paolo
SVP & Chief Medical Officer
—
$252.78K (1) scheduled
−$252.78K
54,365
0.0899%
$449.38K
+574.1%
Honore Tage
Director
—
$240.90K (1)
−$240.90K
135,069
0.2234%
$1.12M
—
Reverberi Gian Piero
SVP & Chief Commercial Officer
—
$81.00K (6)
−$81.00K
165,384
0.2735%
$1.37M
+313.5%
Chrousos Phaedra
Director
—
$40.13K (1)
−$40.13K
164,950
0.2728%
$1.36M
—
Ward Anne Sempowski
Director
—
—
—
160,667
0.2657%
$1.33M
—
McGuire Daniel Patrick
SVP, GC and Secretary
—
—
—
109,982
0.1819%
$909.10K
+266.8%
Duncan Charles Cliff
Director
—
—
—
98,701
0.1632%
$815.85K
—
COLA MICHAEL F
Director
—
—
—
15,000
0.0248%
$123.99K
—
MILANO VINCENT
Director
—
—
—
10,000
0.0165%
$82.66K
—
BATE KENNETH
Director
—
—
—
5,000
0.0083%
$41.33K
—

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Moran Kevin Patrick
6 Dec 2022
SVP, CFO & Treasurer
Sold after exercise
4,792
$10.61
$50.83K
Polymeropoulos Mihael Hristos
6 Dec 2022
President and CEO
Sold after exercise
48,250
$10.61
$512.08K
Polymeropoulos Mihael Hristos
5 Dec 2022
President and CEO
Sold after exercise
47,650
$10.62
$506.20K
Watkins Thomas
2 Jun 2022
Director
Sold after exercise
6,441
$9.90
$63.78K
DUGAN RICHARD W
31 May 2022
Director
Sold after exercise
6,500
$9.85
$64.05K
Polymeropoulos Mihael Hristos
1 Dec 2021
President and CEO
Sold after exercise
46,200
$16.00
$739.35K
Polymeropoulos Mihael Hristos
30 Nov 2021
President and CEO
Sold after exercise
50,000
$16.49
$824.28K
Jones Aranthan II
15 Sep 2021
Chief Corp. Affairs Officer
Sold after exercise
16,824
$16.49
$277.39K
Mitchell Stephen Ray
9 Sep 2021
Director
Sold after exercise
19,109
$16.74
$319.98K
Mitchell Stephen Ray
15 Jun 2021
Director
Sold after exercise
5,000
$19.42
$97.12K
Jones Aranthan II
15 Mar 2021
Chief Corp. Affairs Officer
Sold after exercise
18,000
$17.72
$319.01K
Jones Aranthan II
24 Feb 2021
Chief Corp. Affairs Officer
Sold after exercise
22,986
$20.01
$460.03K
DUGAN RICHARD W
16 Feb 2021
Director
Sold after exercise
5,754
$18.54
$106.66K
Watkins Thomas
16 Feb 2021
Director
Sold after exercise
5,818
$18.54
$107.86K
Polymeropoulos Mihael Hristos
15 Dec 2020
President and CEO
Sold after exercise
39,150
$13.00
$508.84K
Polymeropoulos Mihael Hristos
14 Dec 2020
President and CEO
Sold after exercise
51,049
$13.19
$673.31K
Polymeropoulos Mihael Hristos
11 Dec 2020
President and CEO
Sold after exercise
35,053
$12.88
$451.36K
Watkins Thomas
29 May 2020
Director
Sold after exercise
9,677
$11.50
$111.29K
DUGAN RICHARD W
28 May 2020
Director
Sold after exercise
10,129
$11.04
$111.81K
Polymeropoulos Mihael Hristos
12 Dec 2019
President and CEO
Sold after exercise
70,036
$16.98
$1.19M
Polymeropoulos Mihael Hristos
11 Dec 2019
President and CEO
Sold after exercise
72,373
$16.92
$1.22M
DUGAN RICHARD W
26 Aug 2019
Director
Sold after exercise
15,000
$14.85
$222.75K
Polymeropoulos Mihael Hristos
21 May 2019
President and CEO
Sold after exercise
72,872
$15.34
$1.12M
Polymeropoulos Mihael Hristos
20 May 2019
President and CEO
Sold after exercise
67,418
$15.12
$1.02M
Polymeropoulos Mihael Hristos
17 May 2019
President and CEO
Sold after exercise
77,225
$15.56
$1.20M
Gulino Richard L.
2 Jan 2018
SVP, General Counsel & Sec.
Sold after exercise
10,367
$15.20
$157.56K
Kelly James Patrick
2 Jan 2018
EVP & Chief Financial Officer
Sold after exercise
9,155
$15.35
$140.49K
Polymeropoulos Mihael Hristos
2 Jan 2018
President and CEO
Sold after exercise
21,535
$15.30
$329.40K
Polymeropoulos Mihael Hristos
2 Jan 2018
President and CEO
Sold after exercise
170,225
$15.30
$2.60M
Polymeropoulos Mihael Hristos
3 Jan 2017
President and CEO
Sold after exercise
23,330
$15.48
$361.24K
Kelly James Patrick
3 Jan 2017
SVP, CFO & Treasurer
Sold after exercise
10,895
$15.51
$169.01K
Gulino Richard L.
3 Jan 2017
SVP, General Counsel & Sec.
Sold after exercise
10,900
$15.51
$169.09K
Baroldi Paolo
3 Jan 2017
SVP & Chief Medical Officer
Sold after exercise
16,300
$15.51
$252.78K
Show all 169 transactions →

What was left out

Form 4 filings counted 219
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 33
Sales at will 118
Transactions with no price 0
Shares from compensation/vesting 7,423,904
Sales filed before the plan box existed 93
History held since 19 Sep 2016